Pyoderma Gangrenosum
- 1 June 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 114 (6) , 906-911
- https://doi.org/10.1001/archderm.1978.01640180040010
Abstract
• A 34-year-old man with chronic active hepatitis and pyoderma gangrenosum demonstrated abnormalities in neutrophil and monocyte function. Monocytes from this man had diminished chemotaxis and bacterial phagocytosis. These functions were significantly improved in vitro after one hour of incubation of monocytes with 105hydrocortisone. Neutrophil function was normal for bactericidal activity and phagocytosis, but neutrophil chemotaxis was diminished. A plasma inhibitor was not found to explain these phagocyte alterations. (Arch Dermatol114:906-911, 1978)Keywords
This publication has 6 references indexed in Scilit:
- Transfer Factor for the Treatment of Chronic Active HepatitisNew England Journal of Medicine, 1979
- Pyoderma Gangrenosum and LeukemiaArchives of Dermatology, 1973
- PYODERMA GANGRENOSUM WITH ALTERED CELLULAR IMMUNITY AND DERMONECROTIC FACTOR*British Journal of Dermatology, 1972
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971
- PYODERMA GANGRENOSUM WITH A MONOCLONAL IgM RED CELL AGGLOMERATING FACTORBritish Journal of Dermatology, 1971
- THE SHWARTZMAN PHENOMENON: A REVIEW WITH A CONSIDERATION OF SOME POSSIBLE DERMATOLOGICAL MANIFESTATIONS.British Journal of Dermatology, 1953